IBD Collaborative: IBD & Pouchitis 9.14.21
* Share IBD treatment advancements, especially related to pouchitis complications.
* Explore IBD and pouchitis complications from a multidisciplinary approach.
* Network among regional gastroenterology colleagues.
7:00 pm Welcome Marc Schwartz, MD
7:05 pm Updates on Medical Management of Pouchitis Sandra El-Hachem, MD
7:15 pm IBD & Pouchitis: Advanced Endoscopist’s View Gursimran Kochhar, MD
7:25 pm IBD & Pouchitis: Surgeon’s View Kenneth K.W. Lee, MD
7:35 pm Discussion & Q&A Among All Participants – Case Questions Welcome Moderator: Marc Schwartz, MD
8:00 pm Course Adjourns – Virtual Exhibits Remain Open
The following relevant financial relationships was disclosed:
Sandra El-Hachem, MD is on the speakers' bureau for Abbvie, Janssen, Pfizer, Takeda, UCB/Ferring, Prometheus, Bristol Myers Squibb
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Marc Schwartz, MD
Gursimran Kochhar, MD
Kenneth K.W. Lee, MD
Moderator: Marc Schwartz, MD
Accreditation and credit designation
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 Attendance
Bistol Meyers Squibb
Tekeda Pharmaceuticals America, Inc